Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
0(0%)
Results Posted
100%(6 trials)
Terminated
3(33%)

Phase Distribution

Ph phase_3
2
22%
Ph phase_4
2
22%
Ph not_applicable
2
22%
Ph phase_2
3
33%

Phase Distribution

0

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
3(33.3%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

6 of 9 finished

Non-Completion Rate

33.3%

3 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(6)
Terminated(3)

Detailed Status

Completed6
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (33.3%)
Phase 32 (22.2%)
Phase 42 (22.2%)
N/A2 (22.2%)

Trials by Status

terminated333%
completed667%

Recent Activity

0 active trials
Showing 5 of 9
terminatednot_applicable

Testosterone & Tamoxifen Trial

NCT05156606
completedphase_4

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

NCT03518034
terminatednot_applicable

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

NCT00467987
completedphase_3

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

NCT03198728
completedphase_2

Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality

NCT04492553
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05156606Not Applicable

Testosterone & Tamoxifen Trial

Terminated
NCT03518034Phase 4

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Completed
NCT00467987Not Applicable

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

Terminated
NCT03198728Phase 3

Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men

Completed
NCT04492553Phase 2

Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality

Completed
NCT00350701Phase 4

Effect of Androgel on Type 2 Diabetic Males With Hypogonadism

Completed
NCT00351819Phase 2

Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception

Completed
NCT00515112Phase 2

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Terminated
NCT00962637Phase 3

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9